Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) just unveiled an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company, through its subsidiary GP Corp., has entered into a transaction involving the disposal of accounts receivable to Industrial Securities Asset Management. This transaction, valued at RMB440,280,622.20, is part of a series of similar transactions conducted within a 12-month period. The aggregated transactions exceed a 5% threshold, making it a disclosable transaction under Hong Kong’s Listing Rules, subject to reporting and announcement requirements but exempt from shareholder approval.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Average Trading Volume: 1,236,951
Technical Sentiment Signal: Buy
Current Market Cap: HK$44.18B
See more data about 0874 stock on TipRanks’ Stock Analysis page.